RegWardenFDA facility compliance records
Recall

Class II — Mindray DS USA, Inc. dba Mindray North America

Recalling firmMindray DS USA, Inc.
Registered facilityMINDRAY DS USA, Inc. (the firm's only registered facility)
ClassificationClass II
StatusTerminated
ReasonAn issue with the Panorama Central Station may cause the system to spontaneously restart. This may occur after about 49 days of continuous operation. On restart, monitoring will be lost for about 2.5 minutes. Settings and configurations are maintained.
ProductPanorama Patient Monitoring Network. Software Kit 0020-00-0205-19A, View Station Software Kit 0020-00-0206-16A, Work Station Software Kit 0020-00-0207-16A, Software Kit Upgrade TECH-00-910. The Panaroma Patient Monitoring Network is intended for use in a fixed location in the healthcare facility setting as a central viewing station. It is not intended to be directly connected to patient at any time or installed in a patient's vicinity.
Quantity63 products
DistributionNationwide Distribution.
Initiated2015-12-15
Classified2016-01-29
Terminated2017-03-29
Recall numberZ-0701-2016
InitiationVoluntary: Firm initiated

Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this recall record at FDA → (opens in a new tab)

Cite this record

RegWarden. “Class II recall — Mindray DS USA, Inc. dba Mindray North America (Z-0701-2016).” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/recall/72864/

Not open yet

Alerts for Mindray DS USA, Inc.

Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.

Planned

Want a one-page facility brief?

A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.